who medicines strategy - libdoc.who.int - World Health Organization

More documents

Recommendations

Info

WHO MEDICINES STRATEGY 2004-2007 | 54EO 2.4Rational use of TM/CAM byproviders and consumers bypromoting therapeutically sounduse of appropriate TM/CAMRationaleRational use of TM/CAM depends on a range offactors, including the need for adequate training,registration, and licensing of providers, properuse of products of assured quality, and provisionof scientific information and guidance for thepublic.The efficacy and safe practice of TM/CAMtherapies are closely linked to the qualification ofpractitioners. Good practice in TM is dependanton proper training, the registration of practitioners,and the licensing of TM/CAM practice.ProgressIn 2002, WHO published Volume 2 of the WHOmonographs on selected medicinal plants,containing 30 monographs. Volume 3, providingan additional 31 monographs is in the finalstage of production. The European Commissionrecommends WHO monographs to its membersas an authoritative reference on the quality, safety,and efficacy of medicinal plants. Today, over 12other countries use WHO monographs for theirregulation and registration of herbal medicines.In addition, several countries, including Armenia,Benin, Mexico, Malaysia, South Africa andViet Nam, have developed their own nationalmonographs based on the WHO format. In2003, WHO developed guidelines for consumerinformation on the appropriate use of TM/CAM.ChallengesA range of health care professionals serve asqualified providers of TM/CAM, operating withineach country’s national health care deliverysystem and legislative framework. However,many countries do not have a national schemefor training, education, qualification, licensing,and registration of providers of TM/CAM. As aresult, providers of TM/CAM medicines, such asphysicians, nurses and pharmacists, may havelittle training and understanding of how herbalmedicines, for example, impact on the health ofpatients who are often taking other prescriptionmedicines as well. This information is alsorelevant when diagnostic and treatment decisionsare made.
Number of Member StatesCOMPONENTS OF THE STRATEGY | 55Figure 12:Growth of National Institutes60504030201001999 2003Source: Interim summary analysis of WHO globalsurvey on national policy on TM/CAM, 2002- 2003.Traditional medicines are increasingly used outsidethe confines of traditional culture and far beyondtraditional geographical areas, without properknowledge of their context and use. Moreover,they are also used in different doses, extractedin different ways, and used for indications whichare different from their traditional intended use.To compound the problem, contrary to their usein the traditional context, traditional medicinesare now often used in combination with othermedicines – a practice which has become a safetyconcern.There is a widespread misconception that ‘natural’means ‘safe’ and many believe that remedies ofnatural origin carry no risk. Although a great dealof information on TM/CAM is available through avariety of channels, many consumers are unableto evaluate and select reliable information inorder to make a decision on the use of TM/CAMproducts for self-medication.Meeting the challenges 2004-2007Over the next four years WHO will:> continue to develop basic training guidelineson major forms of TM/CAM, includingchiropractice, herbal medicines, and manualtherapies.> continue to develop authoritative referencesfor Member States, such as the WHOmonographs on selected medicinal plants.> organize an inter-regional workshop toimplement WHO guidelines on proper use ofTM/CAM by consumers, to strengthen nationalcapacity in providing reliable consumerinformation on TM/CAM.OUTCOME INDICATORS1999 2003 2007#REPORTING % TARGET#REPORTING % TARGETNo. of countries with national research institute in the field 19 na na 56/127 e 44% e 51%of TM/CAM e
Page 10 and 11:
WHO MEDICINES STRATEGY 2004-2007 |x
Page 12 and 13:
WHO MEDICINES STRATEGY 2004-2007 |x
Page 14 and 15:
WHO MEDICINES STRATEGY 2004-2007 |
Page 23: MEDICINESAND PUBLIC HEALTH
Page 26 and 27: WHO MEDICINES STRATEGY 2004-2007 |
Page 116 and 117:
Page 118 and 119:
Page 120 and 121:
Page 122 and 123:
Page 124 and 125:
Page 126 and 127:
Page 128 and 129:
Page 130 and 131:
Page 132 and 133:
Page 134 and 135:
Page 136 and 137:
Page 138 and 139:
Page 140 and 141:
Page 142 and 143:
Page 144 and 145:
Page 146 and 147:
Page 148 and 149:
Page 150 and 151:
Page 152 and 153:
Page 154 and 155:
Page 157 and 158:
REFERENCES
Page 159 and 160:
REFERENCES | 1471Annual report 2000
Page 161 and 162:
REFERENCES | 14912 th Model List of
show all

who medicines strategy - libdoc.who.int - World Health Organization

Create successful ePaper yourself

Delete template?

Save as template?